Inhibition of human cytomegalovirus protease N o with monocyclic β-lactams
R Deziel, E Malenfant
Index: Deziel; Malenfant Bioorganic and Medicinal Chemistry Letters, 1998 , vol. 8, # 11 p. 1437 - 1442
Full Text: HTML
Citation Number: 57
Abstract
Monocyclic β-lactams have been identified as potent and selective inhibitors of the human cytomegalovirus protease (HCMV) No. Two series of these inhibitors are described, a peptidyl series of compounds and non-peptidic molecules featuring lower molecular weights. The SAR work that lead to the discovery of these inhibitors, together with their synthesis is also disclosed.
Related Articles:
[Barnes, John H.; Fatome, Marc; Jones, Christopher E. L.; Murray, Stephen G. European Journal of Medicinal Chemistry, 1988 , vol. 23, p. 211 - 216]
[Brown, Thomas J.; Chapman, Robert F.; Cook, David C.; Hart, Terance W.; McLay, Iain M.; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 20 p. 3613 - 3624]